Feline Panleukopenie

Die feline Parvovirose, auch feline Panleukopenie genannt, verursacht vor allem bei Katzenwelpen und Jungtieren schwere Erkrankungs- und Todesfälle. Eine frühzeitige Diagnose, entsprechende adäquate Therapie und konsequente Hygienemaßnahmen können lebensrettend sein und die Verbreitung der Infektion verhindern.

Publication History

Article published online:
21 October 2020

• Literatur

• 1 Lutz H, Kohn B, Forterre F. Hrsg. Krankheiten der Katze. 6. Aufl.. Stuttgart: Thieme; 2019
• 2 Greene CE. Feline enteric viral infections. In: Greene CE. ed. Infectious Diseases of the Dog and Cat. 4^th ed. St Louis, Missouri: Elsevier Saunders; 2012: 80-91
• 3 Ikeda Y, Nakamura K, Miyazawa T. et al. Feline host range of canine parvovirus: recent emergence of new antigenic types in cats. Emerg Infect Dis 2002; 8 (04) 341-346
• 4 Miranda C, Parrish CR, Thompson G. Canine parvovirus 2c infection in a cat with severe clinical disease. J Vet Diagn Invest 2014; 26 (03) 462-464
• 5 Decaro N, Buonavoglia D, Desario C. et al. Characterisation of canine parvovirus strains isolated from cats with feline panleukopenia. Res Vet Sci 2010; 89 (02) 275-278
• 6 Stuetzer B, Hartmann K. Feline parvovirus infection and associated diseases. Vet J 2014; 201 (02) 150-155
• 7 Barrs VR. Feline panleukopenia: a re-emergent disease. Vet Clin North Am Small Anim Pract 2019; 49 (04) 651-670
• 8 Selbitz H, Truyen U, Valentin-Weigand P. Hrsg. Tiermedizinische Mikrobiologie, Infektions- und Seuchenlehre. Stuttgart: Enke; 2015
• 9 Jakel V, Cussler K, Hanschmann KM. et al. Vaccination against feline panleukopenia: implications from a field study in kittens. BMC Vet Res 2012; 8: 62
• 10 Kruse BD, Unterer S, Horlacher K. et al. Feline Panleukopenie – differierender Krankheitsverlauf bei Katzen im Alter von unter bzw. über 6 Monaten?. Tierärztl Prax 2011; 39 (K): 237-242
• 11 Litster A, Benjanirut C. Case series of feline panleukopenia virus in an animal shelter. J Feline Med Surg 2014; 16 (04) 346-353
• 12 Kruse BD, Unterer S, Horlacher K. et al. Prognostic factors in cats with feline panleukopenia. J Vet Intern Med 2010; 24 (06) 1271-1276
• 13 Bentinck-Smith J. Feline panleukopenia (feline infectious enteritis) – a review of 574 cases. North Am Vet 1949; 30: 379-384
• 14 Ossent P. Systemic aspergillosis and mucormycosis in 23 cats. Vet Rec 1987; 120 (14) 330-333
• 15 Csiza CK, Scott FW, Gillespie JH. et al. Feline viruses. XIV. Transplacental infections in spontaneous panleukopenia of cats. Cornell Vet 1971; 61 (03) 423-439
• 16 Url A, Truyen U, Rebel-Bauder B. et al. Evidence of parvovirus replication in cerebral neurons of cats. J Clin Microbiol 2003; 41 (08) 3801-3805
• 17 Sharp NJ, Davis BJ, Guy JS. et al. Hydranencephaly and cerebellar hypoplasia in two kittens attributed to intrauterine parvovirus infection. J Comp Pathol 1999; 121 (01) 39-53
• 18 Günzel-Apel A, Bostedt H. Felines Panleukopenie-Virus (FPLV). In: Günzel-Apel A, Bostedt H. Hrsg. Reproduktionsmedizin und Neonatologie von Hund und Katze. Stuttgart: Schattauer; 2016
• 19 Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997; 11 (02) 65-70
• 20 Decaro N, Buonavoglia C. Canine parvovirus – a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155 (01) 1-12
• 21 Reif JS. Seasonality, natality and herd immunity in feline panleukopenia. Am J Epidemiol 1976; 103 (01) 81-87
• 22 Porporato F, Horzinek MC, Hofmann-Lehmann R. et al. Survival estimates and outcome predictors for shelter cats with feline panleukopenia virus infection. J Am Vet Med Assoc 2018; 253 (02) 188-195
• 23 Riser WH. Infectious panleukopenia of cats. North Am Veterinarian 1943; 24: 293-298
• 24 Povey RC. Feline panleukopenia – which vaccine?. J Small Anim Pract 1973; 14 (07) 399-406
• 25 Proksch AL, Mende K, Bergmann M. et al. Feline Panleukopenie – Die wichtige Rolle von Antikörpern. Tierärztl Prax (K) 2018; 46 (01) 49-56
• 26 Ständige Impfkommission Veterinärmedizin am Friedrich-Loeffler-Institut. Stellungnahme zur Impfung nach Antikörperbestimmung bei Hund und Katze (2017). Im Internet (Stand Mai 2020): https://www.openagrar.de/receive/openagrar_mods_00030949
• 27 Hartmann K, Day MJ, Thiry E. et al. Feline injection – site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg 2015; 17 (07) 606-613
• 28 Mochizuki M, Akaboshi T. Structural polypeptides of feline parvovirus subspecies viruses. Nippon juigaku zasshi Japan J Vet Sci 1989; 50 (06) 1207-1214
• 29 Parrish C. Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virol 1991; 183 (01) 195-205
• 30 Neuerer FF, Horlacher K, Truyen U. et al. Comparison of different in-house test systems to detect parvovirus in faeces of cats. J Feline Med Surg 2008; 10 (03) 247-251
• 31 Patterson EV, Reese MJ, Tucker SJ. et al. Effect of vaccination on parvovirus antigen testing in kittens. J Am Vet Med Assoc 2007; 230 (03) 359-363
• 32 Schunck B, Kraft W, Truyen U. A simple touch-down polymerase chain reaction for the detection of canine parvovirus and feline panleukopenia virus in feces. J Virol Methods 1995; 55 (03) 427-433
• 33 Schatzberg SJ, Haley NJ, Barr SC. et al. Polymerase chain reaction (PCR) amplification of parvoviral DNA from the brains of dogs and cats with cerebellar hypoplasia. J Vet Intern Med 2003; 17 (04) 538-544
• 34 Ryser-Degiorgis MP, Hofmann-Lehmann R, Leutenegger CM. et al. Epizootiologic investigations of selected infectious disease agents in free-ranging Eurasian lynx from Sweden. J Wildl Dis 2005; 41 (01) 58-66
• 35 Mohr AJ, Leisewitz AL, Jacobson LS. et al. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med 2003; 17 (06) 791-798
• 36 Lee JA, Cohn LA. Fluid therapy for pediatric patients. Vet Clin North Am Small Anim Pract 2017; 47 (02) 373-382
• 37 Macintire DK. Pediatric fluid therapy. Vet Clin North Am Small Anim Prac 2008; 38 (03) 621-627
• 38 Gelatt KN, van der Woerdt A, Ketring KL. et al. Enrofloxacin-associated retinal degeneration in cats. Vet Ophthal 2001; 4 (02) 99-106
• 39 Erläuterungen zur zweiten Verordnung zur Änderung der Verordnung über Tierärztliche Hausapotheken vom 21. Februar 2018 (BGBl. I S. 213–216). Im Internet (Stand: Mai 2020): https://www.bundestieraerztekammer.de/btk/dtbl/archiv/artikel/9/2018/anmerkungen-zur-neuen-taehav
• 40 Mochizuki M, Nakatani H, Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet Microbiol 1994; 39 (1 – 2): 145-152
• 41 Martin V, Najbar W, Gueguen S. et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002; 89 (2 – 3): 115-127
• 42 De Mari K, Maynard L, Eun HM. et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 2003; 152 (04) 105-108
• 43 Paltrinieri S, Crippa A, Comerio T. et al. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration. Vet Immunol Immunopathol 2007; 118 (1 – 2): 68-74
• 44 Wolfesberger B, Tichy A, Affenzeller N. et al. Clinical outcome of 73 cases with feline panleukopenia. Wien Tierarztl Monatsschr 2012; 99 (09) 11-17
• 45 Gerlach M, Proksch AL, Unterer S. et al. Efficacy of feline anti-parvovirus antibodies in the treatment of canine parvovirus infection. J Small Anim Pract 2017; 58 (07) 408-415
• 46 Bragg RF, Duffy AL, DeCecco FA. et al. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection. J Am Vet Med Assoc 2012; 240 (06) 700-704
• 47 Kraft W, Kuffer M. Treatment of severe neutropenias in dogs and cats with filgrastim. Tierarztl Prax 1995; 23 (06) 609-613
• 48 Rewerts JM, McCaw DL, Cohn LA. et al. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998; 213 (07) 991-992
• 49 Mischke R, Barth T, Wohlsein P. et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 2001; 70 (03) 221-225
• 50 Henry CJ, Buss MS, Lothrop CD. Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part 1. Oncology. Comp Cont Ed Pract Vet 1998; 20: 728-735
• 51 Proksch AL, Unterer S, Truyen U. et al. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection. Vet J 2014; 202 (02) 340-347
• 52 Pereira GQ, Gomes LA, Santos IS. et al. Fecal microbiota transplantation in puppies with canine parvovirus infection. J Vet Intern Med 2018; 32 (02) 707-711
• 53 Ständige Impfkommission Veterinärmedizin am FLI. Leitlinie zur Impfung von Kleintieren (2019). 4. Aufl. Im Internet (Stand: Mai 2020): https://www.openagrar.de/servlets/MCRFileNodeServlet/openagrar_derivate_00020078/Impfleitlinie-Kleintiere_2019-02-01.pdf
• 54 Ständige Impfkommission Veterinärmedizin am FLI. Empfehlungen zur guten Impfpraxis in der Veterinärmedizin. Im Internet (Stand: Mai 2020): https://www.ltk-bw.de/files/LTK-BW/07_Aktuelles/2018-09-26_Stellungnahme_gute_Impfpraxis.pdf
• 55 Ausschuss der Deutschen Veterinärmedizinischen Gesellschaft e. V.. Desinfektion in der Veterinärmedizin. DVG-Desinfektionsmittelliste für die Tierärztliche Praxis und für Tierheime. DVG-Desinfektionsmittelliste für den Tierhaltungsbereich (2019). Im Internet (Stand: Mai 2020): http://www.desinfektion-dvg.de/index.php?id=2151